2016

Investor Release for the Quarter and Half year ended September 30, 2016
Outcome of the Board Meeting held on November 09, 2016

This is to inform you that the Board of Directors at their meeting held on November 09, 2016 has approved the Unaudited financial results for the quarter and half year ended September 30, 2016.

 

 

Notice of Board Meeting to be held on November 09, 2016 and Closure of Trading Window

This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, November 09, 2016 at the Corporate Office of the Company at Mumbai, to interalia, consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2016.

Further, in terms of the Code of Conduct adopted by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company will remain closed for all the Directors and Designated employees from November 02, 2016 to November 11, 2016 (both days inclusive).

Details of Voting Results through E-voting and Poll under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, at the Annual General Meeting of the Company held on 17th September, 2016
Outcome of the 76th Annual General Meeting held on September 17, 2016

This is to inform you that 76th Annual General Meeting of the members of FDC Limited was held on 17th September, 2016 at 10.00 a. m at WelcomHotel Rama International, R-3, Chikalthana, Aurangabad– 431 210, wherein the members have approved the following resolutions.

  1. Adoption of the Audited Standalone Financial Statements and Audited Consolidated Financial Statement for the year ended March 31, 2016 and Reports thereon.
  2. Confirmation of Interim Dividend of Rs. 2.25/- (225%), as Final Dividend for the financial year ended 31st March, 2016.
  3. Appointment of Ms. Nomita R. Chandavarkar (DIN:00042332), Wholetime Director  who retires by rotation and being eligible offers herself for re-appointment.
  4. Re-appointment of M/s. S R B C & Co. LLP, Chartered Accountants, as the Statutory Auditors and authorize the Board to fix their remuneration.
  5. Re-appointment of Mr. Ashok A. Chandavarkar (DIN: 00042719) as a Wholetime Director for a period of 5 (Five years) with effect from February 29,2016.
  6. Appointment of CA. Uday Kumar Gurkar (DIN: 01749610) as a Non Executive and Independent   Director for a period of 5 (Five years) with effect from April 01,2016.
  7. Ratification of Remuneration of M/s. Sevekari Khare & Associates, Cost Auditors for the financial year ending March 31, 2017.

The said meeting had the required quorum and all the resolutions were passed with requisite majority.

 

Public Notice of 76th Annual General Meeting, Remote E-Voting Information and Book Closure in Newspapers
Outcome of the Board Meeting held on August 12,2016

This is to inform you that the Board of Directors at their meeting held on August 12, 2016 has approved the Unaudited financial results for the quarter ended June 30, 2016.

 

 

Intimation of the Book Closure Notice for the purpose of Annual General Meeting

This is to inform you that, the Seventy Sixth Annual General Meeting of the Company is scheduled to be held on Saturday, 17th September 2016, at WelcomHotel Rama International, R-3, Chikalthana, Aurangabad– 431 210 at 10.00 a.m.

        

Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015, it is hereby informed that the Share Transfer Books and the Register of Members of the Company will remain closed from 08th September, 2016 to 17th September 2016 (both days inclusive) for the purpose of Annual General Meeting.

Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015

This is to inform you that, pending legal cases before the Hon’ble Supreme Court, relating to alleged overcharging, under the Drugs (Price Control) Order 1995, have been disposed of, and the writ petition filed before the Hon’ble Supreme Court stands withdrawn. The Court has granted liberty to the Writ Petitioners to approach the appropriate High Courts for reliefs, challenging the impugned demand notice issued by Union of India.

As per the demand notice in relation to overcharging received by the Company,  the alleged overcharged amount is around Rs. 5.95 Crores (Rupees Five Crores and Ninety Five Lacs Only). The Company shall approach appropriate judicial/regulatory authority in this context.

Notice of Board Meeting to be held on August 12, 2016 and Closure of Trading Window

This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, August 12, 2016 at the Corporate Office of the Company at Mumbai, to interalia, consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2016.

Further, in terms of the Code of Conduct adopted by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company will remain closed for all the Directors and Designated employees from August 05, 2016 to August 14, 2016 (both days inclusive).

Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015

This is to inform you that:

1.Inspection of our manufacturing unit situated at Waluj, District- Aurangabad, Maharashtra, by US Food and Drug Administration (US FDA) has been completed on July 01, 2016. The US FDA has made two minor observations for which appropriate steps shall be taken by the Company.

The above audit was carried out in relation to cGMP inspection and ANDA filed by the Company for product Dorzolamide Ophthalmic Solution.

2.Further, the Company has also received the Establishment Inspection Report (EIR) from US FDA for its manufacturing unit situated at Baddi, Himachal Pradesh with “No observations”. This approval confirms the closure of inspection conducted in February’ 2016. The said audit was carried out in relation to cGMP inspection and ANDA filed by the Company for product Cefixime 400 mg tablet.

Investor Release for the Quarter and Year ended March 31, 2016
Outcome of the Board Meeting held on May 26, 2016

This is to inform you that the Board of Directors at their meeting held on May 26, 2016 has approved the Audited Financial results (Standalone and Consolidated) for the quarter and year ended March 31, 2016.

Further, the Board has recommended that the interim dividend of Rs. 2.25/- (225%) per Equity share having face value of Re. 1 each, paid on March 23, 2016, be considered as final dividend for the year ended March 31, 2016.

Conference Call on May 26,2016,to discuss the results for the quarter & financial year ended March 31, 2016

This   is   to   inform, that a conference call is slated for May 26, 2016. The details are as follows:

Purpose

To discuss the results for the quarter and financial year ended March 31, 2016

Date

May 26, 2016

Time

5.00 p.m. – 5.30 p.m. (IST)

Dial-in Numbers

+91 22 3071 9279 / +91 22 3071 9303

The Company will be represented by Mr. Sanjay Jain, Chief Financial Officer and  Ms. Varsharani Katre, Company Secretary.

Notice of Board Meeting to be held on May 26, 2016 and Closure of Trading Window

This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 26, 2016 at the Corporate Office of the Company at Mumbai, to interalia, consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2016.

Also, please note the Board will also interalia, consider the recommendation of dividend, if any, for the year ended 31st March, 2016.

Further, in terms of the Code of Conduct adopted by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company will remain closed for all the Directors and Designated employees from May 19, 2016 to May 28, 2016 (both days inclusive). 

Public Notice dated March 31, 2016 for WPI index linked MRP redcution
Outcome of the meeting of Independent Directors held on March 31, 2016

This is to inform you that a meeting of Independent Directors of FDC Limited was held on Thursday, March 31, 2016 at the Corporate Office of the Company at Mumbai and inter-alia transacted the following business:

  1. Reviewed the performance of Non Independent Directors and the Board as a whole;
  2. Reviewed the performance of the Chairman of the Company; and
  3. Evaluated the quality, quantity and timeliness of flow of information between the Company management and Board that is necessary for the Board to effectively and reasonably perform their duties.
Notice of Record Date fixed for the purpose of Interim Dividend for Financial year 2015-2016

NOTICE IS HEREBY given that FDC Limited has fixed Saturday, March 19, 2016 as the Record date to determine the eligibility of the Equity Shareholders and Beneficial owners to receive Interim Dividend, as declared by the Board at its meeting held on March 09, 2016.

Securities and Exchange Board of India (SEBI) has stipulated that all listed companies shall use approved electronic mode of payment viz., ECS, NECS. NEFT etc. for the purpose of making payments to the shareholders.

All the shareholders are requested to immediately update their Bank Account No. with 9-digit MICR Code, if the same has not been updated with the Company’s share transfer agent or the depository participant, as the case may be.

Please keep your most updated email id registered with the Company/ your Depository Participant to receive timely communications.

                                                                                                                                                               

Outcome of Board Meeting held on March 09, 2016

This   is   to   inform   you   that the Board of Directors of the Company at its meeting held on  March 09, 2016, has declared Interim Dividend @ Rs. 2.25(225%) per Equity share of Re. 1 each, for the financial year ending March 31, 2016.

Further, the Company has fixed March 19, 2016 as the Record Date for the purpose of payment of Interim dividend. The dividend will be paid to the Shareholders on March 23, 2016.
 

Notice of Board Meeting to be held on March 09, 2016 and Closure of Trading Window

This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, March 09, 2016 at the Corporate Office of the Company at Mumbai, to inter alia, consider and declare the payment of Interim Dividend to the shareholders of the Company for the Financial Year 2015-16.

Further, in terms of the Code of Conduct adopted by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company will remain closed for all the Directors and Designated employees from March 03, 2016 to March 11, 2016 (both days inclusive).

Contact Details of the Authorised Key Managerial Personnel under Regulation 30 (5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find below the contact details of the Key Managerial Personnel authorised by the Board of Directors of the Company, for determining the materiality of an event or information and for the purpose of making disclosures to the Stock Exchanges are as follows:

  1. Mr. Mohan A. Chandavarkar,Chairman & Managing Director

          FDC Limited, 142-48, S.V.Road, Jogeshwari (West), Mumbai- 400 102

          Tel: 022- 3071 9100;Email ID: mac@fdcindia.com

     

      2.Mr. Sanjay Jain, Chief Financial Officer

         FDC Limited, 142-48, S.V.Road, Jogeshwari (West), Mumbai- 400 102

        Tel: 022- 3071 9279;Email ID: sanjay.jain@fdcindia.com

 

    3. Ms. Varsharani Katre, Company Secretary

        FDC Limited, 142-48, S.V.Road,Jogeshwari (West), Mumbai- 400 102

        Tel: 022- 3071 9205;Email ID: varsharani.katre@fdcindia.com

Appointment of Mr. Uday Kumar Gurkar as an Additional, Independent Non- Executive Director w.e.f April 01, 2016

This is to inform you that Mr. Uday Kumar Gurkar has been appointed as an Additional, Non-Executive Independent Director of the Company with effect from April 01, 2016 by the Board of Directors, on the recommendation of the Nomination and Remuneration Committee, at their meeting held on February 06, 2016.

Outcome of Board meeting held on February 06, 2016

This is to inform you that the Board of Directors at their meeting held on February 06, 2016 has approved the Unaudited financial results of the Company for the quarter and nine months ended December 31, 2015.

Notice of Board Meeting to be held on February 06, 2016 and Closure of Trading Window

This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, February 06, 2016 at the Corporate Office of the Company at Mumbai, to inter alia, consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2015. 

Further, in terms of the Code of Conduct adopted by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company will remain closed for all the Directors and Designated employees from January 30, 2016 to February 07, 2016 (both days inclusive).